7/31/2019 Perda de Heterozigosidade e Leucoplasia

1/2

Si{an ai Giqi{jzhlj}hanai i @iymjs`n}hn

Nyqj{i}?

A{n& En{hfn Ljfn`ti} Ahfhz i%enh`? en{hfnahfhzClenh`&mje

S{jd& [hmn{aj ]nfqhnlj Ljeiz i%enh`? {}ljeizCydel&k{

N si{an ai giqi{jzhlj}hanai '@JG( ye difeifj khj`lhmj {i}y`qnfqi

ai tn{hni} nekhifqnh} i*jy lifqhmn} mjej hf}qnkh`hanai} lifehmn},

hfm`yhfaj fj ah}oyfj ehqqhmn i {imjekhfnj, si{an m{jej}}jen`, eyqnj

i ai`ij aj AFN, q{nf}`jmnj i mjfti{}j lfhmn& J} i}qyaj} ai @JG

haifqhdhmne eyanfn} fn aj}nlie ai ye n`i`j giqi{jzhljqj ie {i`nj nj

jyq{j n`i`j, ie ye en{mnaj{ lifqhmj ' Ti{ dhly{n nknhwj(& N nf`h}i ie

fijs`n}hn} li{n`eifqi mjfayzhan mje nej}q{n} sn{inan} qyej{*qimhaj

fj{en & I}qn nf`h}i haifqhdhmn {ilhi} ai @JG iwnehfnfaj n`qi{ni} fj

}qnqy} lifehmj ai m`y`n} fj{enh} mje m`y`n} qyej{nh} aj ei}ej snmhifqi&

]i n @JG nmjfqimi ie ye lifi }ys{i}}j{ ai qyej{ i j n`i`j {ienfi}mifqi

}jd{i eyqnj, ai`ij jy }h`ifmhneifqj lifqhmj, i}qi itifqj `itn n m`y`n nj

i}qnaj ai giehzhlj}i 'yen n`i`j ai`iq{hj i ye ai`iqnaj( jy gjejzhlj}i sn{n

j n`i`j ai`iq{hj& N mjf}i~yfmhn ai}qi i}qnaj sjai }i{ n hfnqhtnj an dyfj

}ys{i}}j{n ai qyej{, mjfq{hkyhfaj sn{n j ai}iftj`theifqj ai mfmi{ jy

eiq}qn}i& Haifqhdhmnj ai {ilhi} ai @JG nyeifqn j ifqifaheifqj aj}

eimnfh}ej} ai dj{enj ai qyej{i}, sjaifaj dnmh`hqn{ j ai}iftj`theifqj ai

en{mnaj{i} ai s{jlf}qhmj lifqhmj i ai n`tj} qi{nsyqhmj}&

Nqyn`eifqi, qmfhmn} ej`imy`n{i} kie i}qnki`imhan} i {jqhfih{neifqi

y}nan} sn{n iwnehfn{ @JG hfm`yie ghk{hahznj lifehmn, ghk{hahznj

d`yj{i}mifqi hf }hqy i {inj ie mnaihn an sj`hei{n}i 'SM[(& I}qn `qhen

nkj{anlie nfn`qhmn kn}inan fn nes`hdhmnj sj{ SM[ ai }i~yifmhn}

sj`he{dhmn} ie `jmnh} i}q{nqlhmj} aj lifjen yqh hznfaj hfhmhnaj{i}

d`yj{i}mifqi}, }ilyhaj ai nf`h}i aj} shmj} aj i`iq{jdi{jl{nen ~yi dj{ne

li{naj} si`n s{i}ifn aj} s{jayqj} d`yj{i}mifqi} an SM[ 'ti{ dhly{n nknhwj(&

Eiqjaj`jlhn} mje nf`h}i} enh} nes`n} aj lifjen }j qneke yqh`hznan}&

@iymjs`n}hn} j{nh} ns{i}ifqne mje d{i~yfmhn @JG ie n`lyf} lifi}

}ys{i}}j{i} ai qyej{& I}qn n`qi{nj ifmjfq{nan mje enhj{ d{i~yfmhn fn}

`iymjs`n}hn} mje ah}s`n}hn} jy nqhshn} ishqi`hnh} hfqif}n} ie mjesn{nj mje

7/31/2019 Perda de Heterozigosidade e Leucoplasia

2/2

n} `i}i} }ie nqhshn& @i}i} ~yi iwhkie @JG yqh`hznfaj%}i t{hj} en{mnaj{i}

ns{i}ifqne enhj{ s{jknkh`hanai ai q{nf}dj{enj en`hlfn& Ifq{iqnfqj, fn

nf`h}i hfahthayn` i}qi} en{mnaj{i} fj }j mjfdhtih} mjej di{{neifqn} sn{n

ahnlf}qhmj sj{~yi ei}ej `i}i} }ie @JG sjaie }jd{i{ q{nf}dj{enj

en`hlfn& my{hj}j qneke ~yi n eymj}n fj{en` naonmifqi `iymjs`n}hn jy

nj mn{mhfjen sjai qneke iwhkh{ @JG&

@ihnenh}? gqqs?**|||&{hmn{aj}ljeiz&mje*qien}%{i`itnfqi}*si{an%ai%

giqi{jzhlj}hanai%i%`iymjs`n}hn}*

My{tn} {is{i}ifqnqhtn} an nf`h}i ai si{an ai giqi{jzhlj}hanai '@JG(& J

qimhaj fj{en` giqi{jzhljqj i ns{i}ifqn ajh} shmj} {idi{ifqi} n s{i}ifn ai

ajh} n`i`j}& N} m`y`n} qyej{nh} ~yi ns{i}ifqne @JG iwhkie {iayj ai ye

aj} shmj} jy nq ei}ej ny}fmhn mjes`iqn aj shmj& Yen n`qi{nj fn {i`nj?

'n`qy{n n`i`j > fj{en`* n`qy{n n`i`j ; fj{en`( * 'n`qy{n aj n`i`j > qyej{*n`qy{n aj

n`i`j ; qyej{( ~yi }ion 6; jy 03&9 hfahmn @JG&

@ihqy{n mjes`ieifqn{?

% [j}hf ES, Mgifl W, Sjg M, @ne \@, Gynfl XG, @jtn} O, Ki{inf B, Is}qihf

OK, S{haax [, @i FA, _gnfl @& Y}i jd n``i`hm `j}} qj s{iahmq en`hlfnfq {h}b dj{

`j|%l{nai j{n` ishqi`hn` ax}s`n}hn& M`hf Mnf [i} ;33324?=9